ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2014
Innovation in therapeutics development at the NCATS.
Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research.Journal of chemical information and modeling · 2022Article
- The future of translational research on alcohol use disorder.Addiction biology · 2021Article
- A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research.bioRxiv : the preprint server for biology · 2020Article
- Predicting translational progress in biomedical research.PLoS biology · 2019Article
- The price of progress: Funding and financing Alzheimer's disease drug development.Alzheimer's & dementia (New York, N. Y.) · 2018Article
- Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.Journal of Alzheimer's disease : JAD · 2018Review
- Facilitating the commercialization and use of organ platforms generated by the microphysiological systems (Tissue Chip) program through public-private partnerships.Computational and structural biotechnology journal · 2016Review
- The Rescue and Repurposing of Pharmaceuticals: Augmenting the Drug Development Paradigm.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAGArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.